Oxford Biomedica plc
OXB.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £61 | £104 | £141 | £109 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £42 | £13 | £58 | £42 |
| Inventory | £14 | £13 | £13 | £10 |
| Other Curr. Assets | £17 | £11 | £4 | £3 |
| Total Curr. Assets | £133 | £141 | £216 | £164 |
| Property Plant & Equip (Net) | £64 | £76 | £134 | £70 |
| Goodwill | £0 | £0 | £1 | £0 |
| Intangibles | £29 | £31 | £105 | £0 |
| Long-Term Investments | £5 | £4 | £5 | £4 |
| Tax Assets | £0 | £0 | -£5 | -£4 |
| Other NC Assets | £0 | £0 | £5 | £4 |
| Total NC Assets | £98 | £111 | £245 | £73 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £232 | £252 | £460 | £237 |
| Liabilities | – | – | – | – |
| Payables | £10 | £6 | £14 | £5 |
| Short-Term Debt | £4 | £7 | £7 | £2 |
| Tax Payable | £0 | £1 | £2 | £2 |
| Deferred Revenue | £0 | £0 | £19 | £13 |
| Other Curr. Liab. | £44 | £29 | £18 | £11 |
| Total Curr. Liab. | £58 | £44 | £60 | £33 |
| LT Debt | £104 | £108 | £111 | £8 |
| Deferred Rev, NC | £1 | £5 | £1 | £2 |
| Deferred Tax Liab, NC | £0 | £0 | £6 | £0 |
| Other NC Liab. | £7 | £17 | £47 | £6 |
| Total NC Liab. | £113 | £130 | £164 | £17 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £69 | £73 | £75 | £9 |
| Total Liabilities | £171 | £175 | £224 | £50 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £27 | £0 |
| Common Stock | £53 | £48 | £48 | £43 |
| Retained Earnings | -£400 | -£353 | -£199 | -£166 |
| AOCI | £9 | -£2 | -£27 | £2 |
| Other Equity | £395 | £380 | £355 | £308 |
| Total Equity | £57 | £74 | £205 | £187 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £3 | £4 | £32 | £0 |
| Total Liab. & Tot. Equity | £232 | £252 | £460 | £237 |
| Net Debt | £48 | £11 | -£24 | -£99 |